NASDAQ:BIAF | Free Cash Flow | bioAffinity Technologies, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$3.23M$5,663.00-$3.23M
2025-12-31-$2.56M$1.00-$2.56M
2025-03-31-$1.64M$50,786.00-$1.69M
2024-12-31-$1.68M$1.00-$1.68M
2024-03-31-$2.35M$41,387.00-$2.39M
2023-12-31-$1.62M-$13,442.00-$1.63M
2023-03-31-$1.53M$32,314.00-$1.56M
2022-12-31-$1.3M
2022-03-31-$633,967.00
2021-12-31-$652,440.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$9.33M$60,568.00-$9.39M
2024-12-31-$7.26M$79,083.00-$7.34M
2023-12-31-$6.04M$22,902.00-$6.06M
2022-12-31-$4.07M$219,987.00-$4.29M
2021-12-31-$2.05M